A3103412
2,3-Dimethylbenzoic acid , 98% , 603-79-2
Synonym(s):
vic.-o-Xylylic acid
CAS NO.:603-79-2
Empirical Formula: C9H10O2
Molecular Weight: 150.17
MDL number: MFCD00002479
EINECS: 210-058-0
Pack Size | Price | Stock | Quantity |
1G | RMB23.20 | In Stock |
|
5G | RMB31.20 | In Stock |
|
25G | RMB87.20 | In Stock |
|
100G | RMB343.20 | In Stock |
|
500g | RMB1679.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 144-146 °C (lit.) |
Boiling point: | 271.51°C (estimate) |
Density | 1.0937 (estimate) |
refractive index | 1.5188 (estimate) |
storage temp. | Sealed in dry,Room Temperature |
form | powder to crystal |
pka | pKa: 3.771(25°C) |
color | White to Almost white |
BRN | 971590 |
InChI | InChI=1S/C9H10O2/c1-6-4-3-5-8(7(6)2)9(10)11/h3-5H,1-2H3,(H,10,11) |
InChIKey | RIZUCYSQUWMQLX-UHFFFAOYSA-N |
SMILES | C(O)(=O)C1=CC=CC(C)=C1C |
Description and Uses
2,3-Dimethylbenzoic Acid is used as a reagent in the synthesis of pyridyl benzamides as inhibitors for the kinetoplastid Trypanosoma brucei. 2,3-Dimethylbenzoic Acid is also used as a reagent in the synthesis of 2,3-Dihydro-1H-isoindole-4-carboxylic Acid (D450070) which is a reagent used in the synthesis of aminoalkylbenzoic acid derivatives for the treatment of faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, neuropathic pain, neuropathological disorders and sleep disorders.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319-H335 |
Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36-36/37/39-22 |
WGK Germany | 3 |
RTECS | DG8734000 |
HazardClass | IRRITANT |
HS Code | 29163990 |